Osteoarthritis
Osteoarthritis (OA) is a whole joint disease at the intersection of rheumatology, immunology and chronic tissue degeneration. It particularly affects patients over 60 years of age, with a prevalence of 30%.
Despite its high prevalence and growing incidence, current options do not adequately address the mechanical failure environment that contributes to disease progression. This places a significant burden on affected individuals and healthcare systems globally. In developed nations, osteoarthritis-related healthcare costs amount to approximately 1.7% of GDP, highlighting the substantial economic impact.
With over 650 million patients worldwide, addressing the unmet needs of those affected requires a concerted effort in research, intervention, and healthcare strategies.
